FI112356B - Kohtalaisen hauras jauhemainen mannitoli ja menetelmä sen valmistamiseksi - Google Patents
Kohtalaisen hauras jauhemainen mannitoli ja menetelmä sen valmistamiseksi Download PDFInfo
- Publication number
- FI112356B FI112356B FI944464A FI944464A FI112356B FI 112356 B FI112356 B FI 112356B FI 944464 A FI944464 A FI 944464A FI 944464 A FI944464 A FI 944464A FI 112356 B FI112356 B FI 112356B
- Authority
- FI
- Finland
- Prior art keywords
- mannitol
- less
- microns
- advantageously
- powdered
- Prior art date
Links
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 title claims abstract description 126
- 235000010355 mannitol Nutrition 0.000 title claims abstract description 125
- 229930195725 Mannitol Natural products 0.000 title claims abstract description 122
- 239000000594 mannitol Substances 0.000 title claims abstract description 122
- 238000000034 method Methods 0.000 title claims description 34
- 238000002360 preparation method Methods 0.000 title claims description 10
- 239000002245 particle Substances 0.000 claims abstract description 74
- 238000012360 testing method Methods 0.000 claims abstract description 14
- 235000013305 food Nutrition 0.000 claims abstract description 8
- 239000000654 additive Substances 0.000 claims abstract description 7
- 238000009826 distribution Methods 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- 239000000945 filler Substances 0.000 claims description 21
- 229920005862 polyol Polymers 0.000 claims description 17
- 150000003077 polyols Chemical class 0.000 claims description 17
- 235000000346 sugar Nutrition 0.000 claims description 15
- 239000000725 suspension Substances 0.000 claims description 12
- 238000004090 dissolution Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 2
- 238000000889 atomisation Methods 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 abstract description 6
- 239000003765 sweetening agent Substances 0.000 abstract description 6
- 239000000546 pharmaceutical excipient Substances 0.000 abstract description 4
- 230000002829 reductive effect Effects 0.000 abstract description 3
- 239000003981 vehicle Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 239000000126 substance Substances 0.000 description 13
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- 238000005507 spraying Methods 0.000 description 10
- 239000006188 syrup Substances 0.000 description 10
- 235000020357 syrup Nutrition 0.000 description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 9
- 239000000600 sorbitol Substances 0.000 description 9
- 235000010356 sorbitol Nutrition 0.000 description 9
- 229920002472 Starch Polymers 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 229960004793 sucrose Drugs 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- 239000011230 binding agent Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 239000000428 dust Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 239000010419 fine particle Substances 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- 150000008163 sugars Chemical class 0.000 description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
- 208000002925 dental caries Diseases 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 229960001375 lactose Drugs 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 239000006199 nebulizer Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 229960001021 lactose monohydrate Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- -1 mannitol Chemical class 0.000 description 2
- 238000002663 nebulization Methods 0.000 description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 229920002245 Dextrose equivalent Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000534944 Thia Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229960004977 anhydrous lactose Drugs 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- NYPJDWWKZLNGGM-RPWUZVMVSA-N esfenvalerate Chemical compound C=1C([C@@H](C#N)OC(=O)[C@@H](C(C)C)C=2C=CC(Cl)=CC=2)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-RPWUZVMVSA-N 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 235000012438 extruded product Nutrition 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical class OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000012803 melt mixture Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000011819 refractory material Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/18—Polyhydroxylic acyclic alcohols
- C07C31/26—Hexahydroxylic alcohols
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Seasonings (AREA)
- General Preparation And Processing Of Foods (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9311513A FR2710637B1 (fr) | 1993-09-28 | 1993-09-28 | Mannitol pulvérulent de friabilité modérée et son procédé de préparation. |
FR9311513 | 1993-09-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI944464A0 FI944464A0 (fi) | 1994-09-27 |
FI944464A FI944464A (fi) | 1995-03-29 |
FI112356B true FI112356B (fi) | 2003-11-28 |
Family
ID=9451298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI944464A FI112356B (fi) | 1993-09-28 | 1994-09-27 | Kohtalaisen hauras jauhemainen mannitoli ja menetelmä sen valmistamiseksi |
Country Status (16)
Country | Link |
---|---|
US (1) | US5573777A (zh) |
EP (1) | EP0645096B1 (zh) |
JP (1) | JP3492428B2 (zh) |
KR (1) | KR100353433B1 (zh) |
CN (1) | CN1046622C (zh) |
AT (1) | ATE160676T1 (zh) |
AU (1) | AU675732B2 (zh) |
CA (1) | CA2133012C (zh) |
DE (1) | DE69407123T2 (zh) |
DK (1) | DK0645096T3 (zh) |
ES (1) | ES2109635T3 (zh) |
FI (1) | FI112356B (zh) |
FR (1) | FR2710637B1 (zh) |
GR (1) | GR3025720T3 (zh) |
HU (1) | HU217453B (zh) |
NO (1) | NO302356B1 (zh) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6235947B1 (en) * | 1997-04-14 | 2001-05-22 | Takeda Chemical Industries, Ltd. | D-mannitol and its preparation |
PL329614A1 (en) † | 1996-04-16 | 1999-03-29 | Bayer Ag | D-mannitoll and method of obtaining same |
DE19615418A1 (de) * | 1996-04-22 | 1997-10-23 | Merck Patent Gmbh | Polyol-Zusammensetzung |
DE19617487A1 (de) † | 1996-05-02 | 1997-11-06 | Merck Patent Gmbh | Geschmacksverbesserung von Arzneimittelwirkstoffen |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
GB9716432D0 (en) * | 1997-08-05 | 1997-10-08 | Cerestar Holding Bv | Tableting of erythritol |
DE19819012A1 (de) * | 1998-04-29 | 1999-11-25 | Dynamit Nobel Ag | Feuersichere, nicht explosionsfähige, Nitroglycerin und wasserfreie Lactose enthaltende Feststoffmischungen |
US6296868B1 (en) * | 1998-11-19 | 2001-10-02 | Advanced Technology Pharmaceuticals Corporation | Chewable tablets containing mannitol and aspartame |
FR2787110B1 (fr) * | 1998-12-11 | 2001-02-16 | Roquette Freres | Sorbitol pulverulent et son procede de preparation |
US20020071864A1 (en) * | 1999-03-25 | 2002-06-13 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
FR2807034B1 (fr) * | 2000-03-29 | 2002-06-14 | Roquette Freres | Mannitol pulverulent et son procede de fabrication |
CA2342121C (fr) * | 2000-03-29 | 2010-05-25 | Roquette Freres | Mannitol pulverulent et son procede de preparation |
EP1343518B1 (en) * | 2000-11-07 | 2009-07-22 | Novartis Vaccines and Diagnostics, Inc. | Stabilized interferon compositions |
CA2439873A1 (en) * | 2001-03-06 | 2002-09-12 | Kyowa Hakko Kogyo Co., Ltd. | Intraorally rapidly desintegrable tablet |
DE10161402A1 (de) * | 2001-12-13 | 2003-06-18 | Merck Patent Gmbh | Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit |
US7118765B2 (en) | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
US7462232B2 (en) | 2002-05-14 | 2008-12-09 | Fmc Corporation | Microcrystalline cellulose compositions |
ES2199061B1 (es) * | 2002-06-10 | 2005-02-16 | Laboratorios Vita, S.A. | Comprimidos bucodispersables y procedimiento para su obtencion. |
US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
US7282217B1 (en) * | 2003-08-29 | 2007-10-16 | Kv Pharmaceutical Company | Rapidly disintegrable tablets |
WO2007034287A2 (en) * | 2005-09-19 | 2007-03-29 | University Of The Witwatersrand, Johannesburg | Oramucosal pharmaceutical dosage form |
US7879382B2 (en) * | 2005-09-30 | 2011-02-01 | Fmc Corporation | Stabilizers and compositions and products comprising same |
JP2009520704A (ja) * | 2005-12-21 | 2009-05-28 | エーディーディー アドバンスト ドラッグ デリバリー テクノロジーズ リミテッド | 水溶性担体を持つコアを含むペレット |
JP5410290B2 (ja) * | 2006-10-27 | 2014-02-05 | エフ エム シー コーポレーション | 共処理組成物とその製造方法、打錠可能な錠剤処方物、錠剤の製造方法及び錠剤 |
GB2450498A (en) | 2007-06-26 | 2008-12-31 | Schlumberger Holdings | Battery powered rotary steerable drilling system |
WO2010021300A1 (ja) | 2008-08-18 | 2010-02-25 | 三菱商事フードテック株式会社 | 新規マンニトール打錠用賦形剤 |
US20100190739A1 (en) * | 2008-12-15 | 2010-07-29 | Fleming And Company, Pharmaceuticals | Rapidly Dissolving Vitamin Formulation and Methods of Using the Same |
FR2949296B1 (fr) * | 2009-09-01 | 2011-11-18 | Roquette Freres | Procede de remplacement total ou partiel du talc dans les chewing-gums |
FR2949462B1 (fr) | 2009-09-01 | 2011-12-16 | Roquette Freres | Poudre de cristaux de mannitol define, son procede de fabrication |
WO2012049156A1 (en) | 2010-10-12 | 2012-04-19 | Bayer Animal Health Gmbh | Non-starch based soft chewables |
WO2013052118A1 (en) | 2011-10-05 | 2013-04-11 | Fmc Corporation | Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
CN103842425B (zh) | 2011-10-05 | 2017-05-24 | Fmc有限公司 | 微晶纤维素和羧甲基纤维素的稳定剂组合物、制备方法和应用 |
BR112014013792B8 (pt) | 2011-12-09 | 2020-11-10 | Dupont Nutrition Usa Inc | composição estabilizadora co-atritada compreendendo carboximetilcelulose de alto grau de substituição e baixa viscosidade, alimento, composição industrial, e, método para fazer a composição estabilizadora |
BE1021954B1 (nl) | 2014-06-05 | 2016-01-28 | Syral Belgium Nv | Samenstelling van sorbitol met lage friabiliteit |
FI4233847T3 (fi) * | 2015-02-26 | 2024-09-24 | Takeda Pharmaceuticals Co | Metoksiureajohdannaista ja mannitolihiukkasia käsittävä tabletti |
FR3038836B1 (fr) | 2015-07-17 | 2017-07-14 | Roquette Freres | Granules de mannitol pour compression directe |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3145146A (en) * | 1961-10-31 | 1964-08-18 | Warner Lambert Pharmaceutical | Modified mannitol for pharmaceutical tablets |
US3341415A (en) * | 1964-02-12 | 1967-09-12 | Warner Lambert Pharmaceutical | Pharmaceutical tablet excipients of solid particles of a binary solid solution of mannitol with a sugar |
JPS5536646A (en) * | 1978-09-06 | 1980-03-14 | Arai Pump Mfg Co Ltd | Double mechanical seal |
US4293570A (en) * | 1979-04-02 | 1981-10-06 | Chimicasa Gmbh | Process for the preparation of sweetener containing product |
FR2571046B1 (fr) * | 1984-10-03 | 1987-10-16 | Roquette Freres | Procede de preparation de mannitol granulaire directement compressible |
FR2571045B1 (fr) * | 1984-10-03 | 1987-12-11 | Roquette Freres | Mannitol granulaire directement compressible et son procede de fabrication |
JPS6185330A (ja) * | 1984-10-04 | 1986-04-30 | Fuji Kagaku Kogyo Kk | 直打用賦形薬の製造法 |
JPS6185331A (ja) * | 1984-10-04 | 1986-04-30 | Fuji Kagaku Kogyo Kk | 直打用賦形薬の製造法 |
ES2066092T3 (es) * | 1990-11-29 | 1995-03-01 | Wei Ming Pharmaceutical Mfg Co | Coadyuvante para la formacion directa de comprimidos. |
JPH06185330A (ja) * | 1992-12-16 | 1994-07-05 | Nissan Motor Co Ltd | エンジンのオイルポンプ支持構造 |
-
1993
- 1993-09-28 FR FR9311513A patent/FR2710637B1/fr not_active Expired - Fee Related
-
1994
- 1994-09-26 US US08/311,791 patent/US5573777A/en not_active Expired - Lifetime
- 1994-09-26 DE DE69407123T patent/DE69407123T2/de not_active Expired - Lifetime
- 1994-09-26 DK DK94402134.4T patent/DK0645096T3/da active
- 1994-09-26 EP EP94402134A patent/EP0645096B1/fr not_active Expired - Lifetime
- 1994-09-26 AT AT94402134T patent/ATE160676T1/de active
- 1994-09-26 ES ES94402134T patent/ES2109635T3/es not_active Expired - Lifetime
- 1994-09-26 AU AU74239/94A patent/AU675732B2/en not_active Expired
- 1994-09-27 CN CN94117872A patent/CN1046622C/zh not_active Expired - Lifetime
- 1994-09-27 HU HU9402773A patent/HU217453B/hu unknown
- 1994-09-27 NO NO943586A patent/NO302356B1/no not_active IP Right Cessation
- 1994-09-27 FI FI944464A patent/FI112356B/fi not_active IP Right Cessation
- 1994-09-27 KR KR1019940024331A patent/KR100353433B1/ko not_active IP Right Cessation
- 1994-09-27 CA CA002133012A patent/CA2133012C/en not_active Expired - Lifetime
- 1994-09-28 JP JP23359994A patent/JP3492428B2/ja not_active Expired - Lifetime
-
1997
- 1997-12-19 GR GR970403367T patent/GR3025720T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI944464A0 (fi) | 1994-09-27 |
DE69407123D1 (de) | 1998-01-15 |
JPH07184590A (ja) | 1995-07-25 |
NO302356B1 (no) | 1998-02-23 |
DE69407123T2 (de) | 1998-04-23 |
ES2109635T3 (es) | 1998-01-16 |
HUT70804A (en) | 1995-11-28 |
FR2710637A1 (fr) | 1995-04-07 |
AU7423994A (en) | 1995-04-13 |
ATE160676T1 (de) | 1997-12-15 |
AU675732B2 (en) | 1997-02-13 |
KR950008457A (ko) | 1995-04-17 |
FR2710637B1 (fr) | 1995-12-08 |
EP0645096B1 (fr) | 1997-12-03 |
CA2133012A1 (en) | 1995-03-29 |
JP3492428B2 (ja) | 2004-02-03 |
KR100353433B1 (ko) | 2002-12-11 |
NO943586D0 (no) | 1994-09-27 |
EP0645096A1 (fr) | 1995-03-29 |
DK0645096T3 (da) | 1998-05-04 |
CN1107516A (zh) | 1995-08-30 |
FI944464A (fi) | 1995-03-29 |
HU9402773D0 (en) | 1994-12-28 |
HU217453B (hu) | 2000-01-28 |
NO943586L (no) | 1995-03-29 |
US5573777A (en) | 1996-11-12 |
CN1046622C (zh) | 1999-11-24 |
CA2133012C (en) | 2006-01-31 |
GR3025720T3 (en) | 1998-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI112356B (fi) | Kohtalaisen hauras jauhemainen mannitoli ja menetelmä sen valmistamiseksi | |
US6180157B1 (en) | Process for preparing an N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester agglomerate | |
US7662799B2 (en) | Powder of amino acids and method for producing the same | |
JPH0386839A (ja) | ソルビトール結晶小球 | |
SK132094A3 (en) | Pharmaceutical dosage form | |
US4973486A (en) | Formulation of lactitol-containing food | |
CA2521253A1 (en) | Pharmaceutical compositions having reduced bitter taste | |
US9636307B2 (en) | Oral pharmaceutical composition comprising taste-masked N-acetylcysteine | |
EP0735042B1 (fr) | Composition de maltitol et son procédé de préparation | |
KR101409302B1 (ko) | 인도메타신 및/또는 아세메타신을 포함하는 약학적 조성물 | |
US5114726A (en) | Process for preparing aspartame coated organic acid | |
MXPA96001193A (en) | Composition of maltitol and process for supreparac | |
FR2732343A1 (fr) | Composition de maltitol et son procede de preparation | |
US5989352A (en) | Lactitol composition and process for the preparation thereof | |
JP3435109B2 (ja) | 瞬溶性顆粒及びその製法 | |
US20220370368A1 (en) | Oral pharmaceutical composition comprising a melt-agglomerated active ingredient core | |
JPH10276715A (ja) | 支持物質上のアスパルテーム |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |